iBio
IBIO
#10296
Rank
A$76.26 M
Marketcap
A$1.08
Share price
-4.00%
Change (1 day)
-35.72%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -A$48.51 Million

According to iBio's latest financial reports the company's current earnings are A$0.1 Million. In 2025 the company made an earning of -A$36.34 Million a decrease over its 2024 earnings that were of -A$20.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$48.51 Million33.49%
2025 -A$36.34 Million75.34%
2024 -A$20.73 Million-32.2%
2023 -A$30.57 Million-50.39%
2022 -A$61.61 Million122.23%
2021 -A$27.73 Million-12.52%
2020 -A$31.69 Million45%
2019 -A$21.86 Million-3.71%
2018 -A$22.7 Million5.52%
2017 -A$21.51 Million18.82%
2016 -A$18.11 Million60.34%
2015 -A$11.3 Million38.31%
2014 -A$8.17 Million25.01%
2013 -A$6.53 Million
2010 -A$18.11 Million360.89%
2009 -A$3.93 Million5.77%
2008 -A$3.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.69 B-56,845.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-A$55.02 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-A$0.23 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.29 Billion 489.86%๐Ÿ‡บ๐Ÿ‡ธ USA